INMB (INmune Bio) FFO per Share


INMB INmune Bio Inc INMB
57 GF Score
Price $1.70
GF Value $1.82
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is INmune Bio FFO per Share?

FFO per Share only applies to REITs.

INMB
57GF Score
INmune Bio Inc INMB
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is INmune Bio (INMB) Overvalued in 2026?

Based on GuruFocus' analysis, INmune Bio stock appears to be undervalued. The current stock price of $1.70 is trading 6.6% below its estimated GF Value™ of $1.82. GuruFocus considers INmune Bio to be Fairly Valued.

Key valuation signals for INMB:

  • FFO per Share:
  • GF Value™: $1.82 vs. price of $1.70 (6.6% below fair value)
  • GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the INMB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

INmune Bio Business Description

Address 225 NE Mizner Boulevard, Suite 640, Boca Raton, FL, USA, 33432
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.
57GF Score

Get the complete analysis for INMB

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.70
Price
$1.82
GF Value